Reduction In The Number Of Early Melanomas Diagnosed During The Covid-19 Pandemic: A Single-Centre Cohort Study

Early detection of melanoma is an important intervention to reduce morbidity and mortality. The COVID-19 pandemic has affected timely access to healthcare, potentially affecting patient outcomes. Marson et al. showed that the incidence of melanoma decreased during the pandemic using United States data. Lallas et al. demonstrated an overall 30.1% decrease in cancers diagnosed during the pandemic in Greece. We sought to evaluate whether melanomas diagnosed during the pandemic at our medical center differed in stage compared to the pre-pandemic time period.